EVALUATION OF SERUM ANTIOXIDANT CAPACITY AND LIVER FUNCTIONS IN HEPATITIS B AND C VIRAL INFECTIONS
Article Sidebar
Main Article Content
Abstract
OBJECTIVE: To investigate the serum antioxidant capacity and status of liver function parameters in Hepatitis B virus (HBV) and Hepatitis C Virus (HCV) infected patients.
METHODS: In this case-control study, fifty patients with HBV (28 male & 22 females), fifty HCV patients (28 male & 22 females) and age and gender matched fifty healthy controls were enrolled from May to August 2016. The antioxidant status was determined by measuring trolox equivalent oxidant capacity (TEAC) through the Ferric Reducing Ability of Plasma assay. Serum levels of alkaline phosphates (ALP), Alanine amino transferase (ALT) and Albumin were estimated.
Results: Serum ALT levels (U/L) were 119.69±5.03 & 24.3±3.01 in male HBV patients and controls; 176.34±75.48 and 25±3.01 in female HBV patients & Controls; 114.71±5.03 and 22.61±2.33 in male HCV patients and controls and 165±5.03 & 25±3.01 in female HCV patients & Controls respectively. Serum ALP levels (U/L) were 317.69±5.13, 240.17±23.9 in male HBV & controls, 159.34±5.03 & 138.4±3 in female HBV & Controls; 129.28±4.57, 230.47±33.5 in male HCV & controls and 169±3.65 and 165.10±5.70 in female HCV & Controls respectively (p<0.01). Serum TEAC (μg/mL) were 266.1±13.71, 413±18.21, 214.42±11.1, 395.71±16.33 in male HBV & control and female HBV & control respectively as compared to 264.6±14.55, 409.8±17.54, 273.4±13.84 and 395.5±14.23 in male HCV & control and female HCV & control respectively (p<0.01).
CONCLUSION: A significantly high HBV & HCV induced oxidative stress and deranged liver parameters were observed in male and female patients, suggesting a possible association between viral pathogenesis and level of oxidative stress.
Article Details
Work published in KMUJ is licensed under a
Creative Commons Attribution 4.0 License
Authors are permitted and encouraged to post their work online
(e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
References
Lok A. Chronic hepatitis B. N Engl J Med 2002;346(22):1682-3. https://doi.org/10.1056/nejm200205303462202
Riggio O, Montagnese F, Fiore P, Folino S, Giambartolomei S, Gandin C, et al. Iron overload in patients with chronic viral hepatitis: how common is it? Am J Gastroenterol 1997;92(8):1298-1301.
Zanaboni G, Dyne KM, Rossi A, Monafo V, Cetta G. Prolidase deficiency: biochemical study of erythrocyte and skin fibroblast prolidase activity in Italian patients. Haematologica 1994;79(1):13-8.
Gill SS, Tuteja N. Reactive oxygen species and antioxidant machinery in abiotic stress tolerance in crop plants. Plant Physiol Biochem 2010;48(12):909-30. https://doi.org/10.1016/j.plaphy.2010.08.016
Stehbens WE. Oxidative stress in viral hepatitis and AIDS. Exp Mol Pathol 2004;77(2):121-32. https://doi.org/10.1016/j.yexmp.2004.04.007
Choi J, James Ou J-H. Mechanisms of liver injury. III. Oxidative stress in the pathogenesis of hepatitis C virus. Am J Physiol Gastrointest Liver Physiol 2006;290(5):G847-51. https://doi.org/10.1152/ajpgi.00522.2005
Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Anal Biochem1996;239(1):70-6. https://doi.org/10.1006/abio.1996.0292
Riahi-Zanjani B, Balali-Mood M, Alamdaran S-A. Evaluation of the serum total antioxidant level and hematological indices in healthy workers exposed to low radiation doses: A significant increase in platelet indices. Pharmacologyonline 2014;1:63-7.
Bachschmid MM, Schildknecht S, Matsui R, Zee R, Haeussler D, A. Cohen R, et al. Vascular aging: chronic oxidative stress and impairment of redox signaling - consequences for vascular homeostasis and disease. Ann Med 2013;45(1):17-36. https://doi.org/10.3109/07853890.2011.645498
Biniecka M, Kennedy A, Ng CT, Chang TC, Balogh E, Fox E, et al. Successful tumour necrosis factor (TNF) blocking therapy suppresses oxidative stress and hypoxia-induced mitochondrial mutagenesis in inflammatory arthritis. Arthritis Res Ther 2011;13:R121. https://doi.org/10.1186/ar3424
Mrakic-Sposta S, Gussoni M, Montorsi M, Porcelli S, Vezzoli A. Assessment of a standardized ROS production profile in humans by electron paramagnetic resonance. Oxid Med Cell Longev 2012;2012:973927. https://doi.org/10.1155/2012/973927
Chrobot AM, Szaflarska-Szczepanik A, Drewa G. Antioxidant defense in children with chronic viral hepatitis B and C. Medical Science Monitor. 2000 Jul 1;6(4):713-8.
Khan AR, Awan FR, Najam S, Islam M, Siddique T, Zain M. Elevated serum level of human alkaline phosphatase in obesity. J Pak Med Assoc 2015;65(11):1182-5.
Della CC, Nobili V, Comparcola D, Cainelli F, Vento S. Management of chronic hepatitis B in children: an unresolved issue. J Gastroenterol Hepatol 2014;29(5):912-9. https://doi.org/10.1111/jgh.12550
Larrea E, Beloqui O, Muñoz-Navas M-A, Civeira Ma-P, Prieto J. Superoxide dismutase in patients with chronic hepatitis C virus infection. Free Radic Biol Med 1998;24(7-8):1235-41. https://doi.org/10.1016/s0891-5849(97)00437-1
Prandota J. Autism spectrum disorders may be due to cerebral toxoplasmosis associated with chronic neuroinflammation causing persistent hypercytokinemia that resulted in an increased lipid peroxidation, oxidative stress, and depressed metabolism of endogenous and exogenous substances.Res Autism Spectr Disord 2010;4(2):119-55. http://dx.doi.org/10.1016/j.rasd.2009.09.011
Ni H, Soe HHK, Htet A. Determinants of abnormal liver function tests in diabetes patients in Myanmar. Int J Diabetes Res 2012;1(3):36-41. https://doi.org/10.5923/j.diabetes.20120103.02
Arnold DT, Bentham LM, Jacob RP, Lilford RJ, Girling AJ. Should patients with abnormal liver function tests in primary care be tested for chronic viral hepatitis: cost minimisation analysis based on a comprehensively tested cohort. BMC Fam Pract 2011;12(1):1-9. https://doi.org/10.1186/1471-2296-12-9
Bernardi M, Maggioli C, Zaccherini G. Human albumin in the management of complications of liver cirrhosis. Crit Care 2012;16:211. https://doi.org/10.1186/cc11218
Şen V, Uluca Ü, Ece A, Kaplan İ, Bozkurt F, Aktar F, et al. Serum prolidase activity and oxidant– antioxidant status in children with chronic hepatitis B virus infection. Ital J Pediatr 2014;40:95. https://doi.org/10.1186/s13052-014-0095-1
Meydani SN, Meydani M, Blumberg JB, Leka LS, Siber G, Loszewski R, et al. Vitamin E supplementation and in vivo immune response in healthy elderly subjects: a randomized controlled trial. JAMA 1997;277(17):1380-6. https://doi.org/10.1001/jama.1997.03540410058031